http://www.immunologyproductguide.com/blog A comprehensive guide to immunology products for medical professionals Fri, 11 Jun 2010 10:09:04 +0000 http://wordpress.org/?v=2.8.2 en hourly 1 http://www.immunologyproductguide.com/blog/2008/10/30/fda-nod-to-tibotecs-prezista-for-treating-hiv-1-infection/ http://www.immunologyproductguide.com/blog/2008/10/30/fda-nod-to-tibotecs-prezista-for-treating-hiv-1-infection/#comments Thu, 30 Oct 2008 05:08:36 +0000 Jim Marino http://www.immunologyproductguide.com/blog/2008/10/30/fda-nod-to-tibotecs-prezista-for-treating-hiv-1-infection/ The U.S. Food and Drug Administration has expanded the indication for Tibotec Pharmaceuticals’ PREZISTA (darunavir) tablets once-daily dosing as a part of the HIV combination therapy in adult patients who have not taken medication for HIV before. Also, PREZISTA has been approved as a twice-daily for use in adults with a prior experience of treatment. With this approval, the protease inhibitor when administered with 100 mg PREZISTA/r (ritonavir) and other ARVs (antiretroviral agents) can be used for the treatment of HIV-1 infection.

]]> http://www.immunologyproductguide.com/blog/2008/10/30/fda-nod-to-tibotecs-prezista-for-treating-hiv-1-infection/feed/ 0